In 2017, there were 82 instances of drug-resistant tuberculosis in the Special Region of Yogyakarta, which is one of the regions with the highest incidence of tuberculosis (3,770 cases). Increases in mortality and Lost to Follow Up (LTFU) are affected by age, knowledge, psychological, and economic factors. TB and COVID-19 symptoms are nearly same, however there have not been as much research on COVID-19 infection in TB patients as during the COVID-19 epidemic. The purpose of this study is to determine the reasons why TB drug-resistant patients who are currently undergoing treatment abandon their regimens. A qualitative design with 5 respondents of TB drug-resistance discontinuation in the Special Region of Yogyakarta over the treatment peri...
Tuberculosis (TB) is the leading cause of mortality as a single infectious agent globally with incre...
Multi-drug-resistant tuberculosis (MDR-TB) is a growing problem around the world especially in count...
Introduction: despite the Treatment pulmonary TB patients, defaulting from treatment may remain the ...
In 2017, there were 82 instances of drug-resistant tuberculosis in the Special Region of Yogyakarta,...
The current coronavirus disease 2019 (COVID-19) situation might deteriorate the efforts to eliminate...
Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis complex (MTBC) which...
Background: Tuberculosis (TB) is a chronic infectious disease that remains a major public health iss...
A descriptive quantitative research was used to conduct this study. Purposive sampling was used to c...
Background: During the COVID-19 pandemic in Surakarta, there were patients who were absent, failed, ...
Background: A multitude of factors are known to be associated with tuberculosis (TB) patients droppi...
Background: Tuberculosis (TB) remains the leading infectious cause of adult mortality, despite 60 ye...
Drug Resistant Tuberculosis (DR TB) continues to be a threat to society. The increasing number of tr...
BACKGROUND: Non-adherence to tuberculosis (TB) treatment is an important barrier for TB prevention a...
Background: Despite the implementation of Directly Observed Treatment Short-course (DOTS) strategy i...
Abstract Background Drug-resistant tuberculosis (DR-TB) is the barrier for global TB elimination eff...
Tuberculosis (TB) is the leading cause of mortality as a single infectious agent globally with incre...
Multi-drug-resistant tuberculosis (MDR-TB) is a growing problem around the world especially in count...
Introduction: despite the Treatment pulmonary TB patients, defaulting from treatment may remain the ...
In 2017, there were 82 instances of drug-resistant tuberculosis in the Special Region of Yogyakarta,...
The current coronavirus disease 2019 (COVID-19) situation might deteriorate the efforts to eliminate...
Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis complex (MTBC) which...
Background: Tuberculosis (TB) is a chronic infectious disease that remains a major public health iss...
A descriptive quantitative research was used to conduct this study. Purposive sampling was used to c...
Background: During the COVID-19 pandemic in Surakarta, there were patients who were absent, failed, ...
Background: A multitude of factors are known to be associated with tuberculosis (TB) patients droppi...
Background: Tuberculosis (TB) remains the leading infectious cause of adult mortality, despite 60 ye...
Drug Resistant Tuberculosis (DR TB) continues to be a threat to society. The increasing number of tr...
BACKGROUND: Non-adherence to tuberculosis (TB) treatment is an important barrier for TB prevention a...
Background: Despite the implementation of Directly Observed Treatment Short-course (DOTS) strategy i...
Abstract Background Drug-resistant tuberculosis (DR-TB) is the barrier for global TB elimination eff...
Tuberculosis (TB) is the leading cause of mortality as a single infectious agent globally with incre...
Multi-drug-resistant tuberculosis (MDR-TB) is a growing problem around the world especially in count...
Introduction: despite the Treatment pulmonary TB patients, defaulting from treatment may remain the ...